Flex Pharma, Inc. (NASDAQ:FLKS) Posted Basic Consolidated EPS Of $-2.0767

0

Flex Pharma, Inc. (NASDAQ:FLKS) annual basic consolidated EPS was $-2.0767 for the period ended 2015-12-31. The basic consolidated EPS was $-2.0767 for the quarter ended 2015-12-31.

EPS from continuing operations

Flex Pharma, Inc. (NASDAQ:FLKS)’s basic EPS from continuing operations was $-2.0767 for the fiscal year 2015-12-31. For the quarter ended 2015-12-31 it stood at $-2.0767

EPS contribution from parent

From the parent company Flex Pharma, Inc. (NASDAQ:FLKS) posted basic EPS of $-2.0767 for the fiscal ended 2015-12-31. For the quarter that ended on 2015-12-31 the figure stood at $-2.0767.

Basic net EPS

The Basic net EPS of Flex Pharma, Inc. (NASDAQ:FLKS) was $-2.08 for the period ended 2015-12-31. The figure stood at $-2.08 for the quarter that ended 2015-12-31.

Consolidated diluted EPS

The consolidated diluted EPS for the fiscal year 2015-12-31 stood at $-2.0767. While the figure for the quarter ended 2015-12-31 stood at $-2.0767.

Basic diluted EPS

The diluted EPS from continuing operation of Flex Pharma, Inc. (NASDAQ:FLKS) stood at $-2.0767 for the fiscal 2015-12-31. The figure for the quarter ended 2015-12-31 stood at $-2.0767

Net diluted EPS

The Net diluted EPS was $-2.08 for the fiscal 2015-12-31. The figure for the quarter ended 2015-12-31 stood at $-2.08.

Diluted EPS from parent

Flex Pharma, Inc. (NASDAQ:FLKS) diluted EPS from the parent company for the fiscal 2015-12-31 was $-2.0767. The figure for the quarter ended 2015-12-31 was $-2.0767

The net basic EPS was $-4.42 for fiscal 2015-12-31. The figure for the quarter ended 2015-12-31 was $-4.42.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 2 times, 1 visits today)